Progress in the management of EGFR-mutant NSCLC in 2020: Where are we now?
Watch a webinar and interviews from global experts on the latest data for EGFR-mutant non-small-cell lung cancer (NSCLC) from the American Society of Clinical Oncology Virtual 2020 Conference (ASCO20 Virtual) and their potential implications for optimizing treatment decisions in clinical practice.
CME and Education Activities are developed by touchIME for touchONCOLOGY.
Our education resources are developed in collaboration with our well established peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.